← Back to Screener
Artivion, Inc. (AORT)
Price$20.12
Value ScoreC
Growth ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-64.80%
Price vs S&P 500 (4W)-20.81%
VGM Score42.38
Market Capitalization$976.69M
P/E Ratio (Annual)99.99x
All Metrics
P/CF (Annual)24.49x
Book Value / Share (Quarterly)$9.29
P/TBV (Annual)7.41x
Revenue Growth (3Y)12.04%
Cash Flow / Share (Quarterly)$0.30
Price vs S&P 500 (YTD)-64.04%
Gross Margin (TTM)64.55%
Net Profit Margin (TTM)2.55%
EPS (TTM)$0.24
10-Day Avg Trading Volume0.65M
EPS Excl Extra (TTM)$0.24
Revenue Growth (5Y)11.75%
EPS (Annual)$0.21
ROI (Annual)1.46%
Gross Margin (Annual)64.40%
Net Profit Margin (5Y Avg)-4.20%
Cash / Share (Quarterly)$1.15
P/E Basic Excl Extra (TTM)83.55x
Revenue Growth QoQ (YoY)17.54%
P/E Normalized (Annual)99.99x
ROA (Last FY)1.10%
Revenue Growth TTM (YoY)17.59%
EBITD / Share (TTM)$0.86
ROE (5Y Avg)-5.05%
Operating Margin (TTM)6.04%
Cash Flow / Share (Annual)$0.02
P/B Ratio2.17x
P/B Ratio (Quarterly)3.94x
Net Income / Employee (Annual)$5,400
EV / Revenue (TTM)2.49x
Net Interest Coverage (TTM)1.79x
ROA (TTM)1.35%
EV / EBITDA (TTM)27.13x
EPS Incl Extra (Annual)$0.21
Current Ratio (Annual)3.53x
Quick Ratio (Quarterly)2.32x
3-Month Avg Trading Volume0.57M
52-Week Price Return-30.91%
EV / Free Cash Flow (Annual)1358.98x
P/E Incl Extra (TTM)83.55x
Revenue / Employee (TTM)$254,800
Tangible BV / Share (Quarterly)$6.09
P/S Ratio (Annual)2.21x
Asset Turnover (Annual)0.50x
52-Week High$48.25
Operating Margin (5Y Avg)2.27%
EPS Excl Extra (Annual)$0.21
CapEx CAGR (5Y)39.74%
26-Week Price Return-56.88%
Quick Ratio (Annual)2.20x
13-Week Price Return-46.86%
Total Debt / Equity (Annual)0.49x
Current Ratio (Quarterly)3.86x
Enterprise Value$1.14B
Revenue / Share Growth (5Y)6.95%
Asset Turnover (TTM)0.53x
Book Value / Share Growth (5Y)-1.62%
Revenue / Employee (Annual)$245,200
Inventory Turnover (Annual)1.82x
Pretax Margin (Annual)3.35%
Cash / Share (Annual)$1.36
3-Month Return Std Dev69.15%
Gross Margin (5Y Avg)64.76%
Net Income / Employee (TTM)$6,500
EBITDA CAGR (5Y)18.96%
EBITDA Interim CAGR (5Y)10.60%
ROE (Last FY)2.18%
Net Interest Coverage (Annual)1.93x
EPS Basic Excl Extra (Annual)$0.21
P/FCF (TTM)25.64x
Receivables Turnover (TTM)5.11x
EV / Free Cash Flow (TTM)78.20x
Total Debt / Equity (Quarterly)0.49x
EPS Incl Extra (TTM)$0.24
Receivables Turnover (Annual)5.22x
ROI (TTM)1.78%
P/S Ratio (TTM)2.13x
Pretax Margin (5Y Avg)-2.88%
Revenue / Share (Annual)$9.36
Tangible BV / Share (Annual)$6.10
Forward P/E142.44x
Free OCF CAGR (5Y)-30.14%
Price vs S&P 500 (52W)-55.27%
P/E Ratio (TTM)83.55x
Year-to-Date Return-55.89%
5-Day Price Return-4.42%
EPS Normalized (Annual)$0.21
ROA (5Y Avg)-1.77%
Net Profit Margin (Annual)2.21%
Month-to-Date Return-9.33%
Cash Flow / Share (TTM)$-0.05
EBITD / Share (Annual)$0.82
Operating Margin (Annual)5.46%
LT Debt / Equity (Annual)0.48x
P/CF (TTM)16.84x
ROI (5Y Avg)-2.32%
P/E Excl Extra (TTM)83.55x
LT Debt / Equity (Quarterly)0.48x
EPS Basic Excl Extra (TTM)$0.24
P/TBV (Quarterly)6.01x
P/B Ratio (Annual)4.82x
Inventory Turnover (TTM)1.81x
Pretax Margin (TTM)3.80%
Book Value / Share (Annual)$9.37
Price vs S&P 500 (13W)-55.11%
Beta1.30x
P/FCF (Annual)1164.11x
Revenue / Share (TTM)$9.22
ROE (TTM)2.66%
52-Week Low$19.16
vGradeC
gGradeC
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.03est. 0.05
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.15
4.15
4.31
4.29
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AORTArtivion, Inc. | C | C | D | $20.12 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Artivion provides cardiac and vascular surgeons with aortic-centric surgical solutions, including heart valves, stent grafts, patches, and surgical sealants. The company operates through two segments: Medical Devices (implantable products and surgical tools) and Preservation Services (tissue preservation). With global operations across North America, EMEA, LATAM, and APAC, North America represents its largest revenue source.